Annual Total Debt
$26.28 M
-$7.19 M-21.49%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual total debt is $26.28 million, with the most recent change of -$7.19 million (-21.49%) on December 31, 2023.
- During the last 3 years, PLX annual total debt has fallen by -$38.12 million (-59.19%).
- PLX annual total debt is now -64.10% below its all-time high of $73.22 million, reached on December 31, 2016.
Performance
PLX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$5.68 M
-$20.47 M-78.27%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly total debt is $5.68 million, with the most recent change of -$20.47 million (-78.27%) on September 30, 2024.
- Over the past year, PLX quarterly total debt has dropped by -$20.32 million (-78.14%).
- PLX quarterly total debt is now -95.16% below its all-time high of $117.50 million, reached on March 31, 2017.
Performance
PLX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
PLX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.5% | -78.1% |
| 3 y3 years | -59.2% | -78.1% |
| 5 y5 years | -45.2% | -78.1% |
PLX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.5% | at low | -83.1% | at low |
| 5 y | 5-year | -59.2% | at low | -91.2% | at low |
| alltime | all time | -64.1% | -100.0% | -95.2% | -100.0% |
Protalix BioTherapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.68 M(-78.3%) |
| Jun 2024 | - | $26.15 M(-0.8%) |
| Mar 2024 | - | $26.37 M(+0.3%) |
| Dec 2023 | $26.28 M(-21.5%) | $26.28 M(+1.1%) |
| Sep 2023 | - | $26.01 M(+0.1%) |
| Jun 2023 | - | $25.97 M(-22.6%) |
| Mar 2023 | - | $33.57 M(+0.3%) |
| Dec 2022 | $33.47 M(+0.0%) | $33.47 M(+1.0%) |
| Sep 2022 | - | $33.14 M(+0.4%) |
| Jun 2022 | - | $33.01 M(-1.2%) |
| Mar 2022 | - | $33.40 M(-0.2%) |
| Dec 2021 | $33.47 M(-48.0%) | $33.47 M(-8.9%) |
| Sep 2021 | - | $36.73 M(-40.8%) |
| Jun 2021 | - | $62.10 M(+1.7%) |
| Mar 2021 | - | $61.08 M(-5.2%) |
| Dec 2020 | $64.40 M(+5.7%) | $64.40 M(+1.4%) |
| Sep 2020 | - | $63.54 M(+1.5%) |
| Jun 2020 | - | $62.59 M(+1.5%) |
| Mar 2020 | - | $61.69 M(+1.2%) |
| Dec 2019 | $60.92 M(+27.0%) | $60.92 M(+9.0%) |
| Sep 2019 | - | $55.92 M(+1.3%) |
| Jun 2019 | - | $55.19 M(+1.4%) |
| Mar 2019 | - | $54.42 M(+13.5%) |
| Dec 2018 | $47.97 M(-8.1%) | $47.97 M(+1.4%) |
| Sep 2018 | - | $47.32 M(+1.2%) |
| Jun 2018 | - | $46.74 M(-10.2%) |
| Mar 2018 | - | $52.04 M(-0.3%) |
| Dec 2017 | $52.19 M(-28.7%) | $52.19 M(-18.2%) |
| Sep 2017 | - | $63.84 M(+10.3%) |
| Jun 2017 | - | $57.88 M(-50.7%) |
| Mar 2017 | - | $117.50 M(+60.5%) |
| Dec 2016 | $73.22 M(+1.6%) | $73.22 M(+1.1%) |
| Sep 2016 | - | $72.43 M(+0.2%) |
| Jun 2016 | - | $72.32 M(+0.2%) |
| Mar 2016 | - | $72.21 M(+0.2%) |
| Dec 2015 | $72.10 M(+7.0%) | $72.10 M(+6.4%) |
| Sep 2015 | - | $67.77 M(+0.2%) |
| Jun 2015 | - | $67.67 M(+0.2%) |
| Mar 2015 | - | $67.57 M(+0.3%) |
| Dec 2014 | $67.35 M(+0.5%) | $67.35 M(-0.0%) |
| Sep 2014 | - | $67.36 M(+0.2%) |
| Jun 2014 | - | $67.25 M(+0.2%) |
| Mar 2014 | - | $67.15 M(+0.2%) |
| Dec 2013 | $67.05 M(>+9900.0%) | $67.05 M(+0.2%) |
| Sep 2013 | - | $66.94 M(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(-100.0%) |
| Jun 2012 | - | $4.68 M(>+9900.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00 | $0.00(0.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $4.45 M(>+9900.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | - | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2000 | - | $22.80 K(-60.6%) |
| Jun 2000 | - | $57.80 K(0.0%) |
| Mar 2000 | - | $57.80 K(0.0%) |
| Dec 1999 | $57.80 K(-9.8%) | $57.80 K(-0.2%) |
| Sep 1999 | - | $57.90 K(+0.2%) |
| Jun 1999 | - | $57.80 K(0.0%) |
| Mar 1999 | - | $57.80 K |
| Dec 1998 | $64.10 K(>+9900.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00 | - |
FAQ
- What is Protalix BioTherapeutics annual total debt?
- What is the all time high annual total debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual total debt year-on-year change?
- What is Protalix BioTherapeutics quarterly total debt?
- What is the all time high quarterly total debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly total debt year-on-year change?
What is Protalix BioTherapeutics annual total debt?
The current annual total debt of PLX is $26.28 M
What is the all time high annual total debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual total debt is $73.22 M
What is Protalix BioTherapeutics annual total debt year-on-year change?
Over the past year, PLX annual total debt has changed by -$7.19 M (-21.49%)
What is Protalix BioTherapeutics quarterly total debt?
The current quarterly total debt of PLX is $5.68 M
What is the all time high quarterly total debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly total debt is $117.50 M
What is Protalix BioTherapeutics quarterly total debt year-on-year change?
Over the past year, PLX quarterly total debt has changed by -$20.32 M (-78.14%)